Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.

Xu Y, Ashley T, Brainerd EE, Bronson RT, Meyn MS, Baltimore D.

Genes Dev. 1996 Oct 1;10(19):2411-22.

2.

Atm-deficient mice: a paradigm of ataxia telangiectasia.

Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A.

Cell. 1996 Jul 12;86(1):159-71.

3.

ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia.

Lavin MF, Khanna KK.

Int J Radiat Biol. 1999 Oct;75(10):1201-14. Review.

PMID:
10549596
4.

ATM and RPA in meiotic chromosome synapsis and recombination.

Plug AW, Peters AH, Xu Y, Keegan KS, Hoekstra MF, Baltimore D, de Boer P, Ashley T.

Nat Genet. 1997 Dec;17(4):457-61.

PMID:
9398850
5.
6.

Bone marrow transplantation restores immune system function and prevents lymphoma in Atm-deficient mice.

Bagley J, Cortes ML, Breakefield XO, Iacomini J.

Blood. 2004 Jul 15;104(2):572-8. Epub 2004 Mar 25.

7.

Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles.

Barlow C, Liyanage M, Moens PB, Deng CX, Ried T, Wynshaw-Boris A.

Nat Genet. 1997 Dec;17(4):462-6.

PMID:
9398851
8.

ATM: from gene to function.

Rotman G, Shiloh Y.

Hum Mol Genet. 1998;7(10):1555-63. Review.

PMID:
9735376
9.

Ataxia telangiectasia gene mutations in leukaemia and lymphoma.

Boultwood J.

J Clin Pathol. 2001 Jul;54(7):512-6. Review.

10.
11.

Control of Atm-/- thymic lymphoma cell proliferation in vitro and in vivo by dexamethasone.

Kuang X, Yan M, Liu N, Scofield VL, Qiang W, Cahill J, Lynn WS, Wong PK.

Cancer Chemother Pharmacol. 2005 Mar;55(3):203-12. Epub 2004 Nov 27.

PMID:
15570424
12.

Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice.

Treuner K, Helton R, Barlow C.

Oncogene. 2004 Jun 10;23(27):4655-61.

PMID:
15122331
13.
14.

Atm inactivation results in aberrant telomere clustering during meiotic prophase.

Pandita TK, Westphal CH, Anger M, Sawant SG, Geard CR, Pandita RK, Scherthan H.

Mol Cell Biol. 1999 Jul;19(7):5096-105.

15.

ATM: the product of the gene mutated in ataxia-telangiectasia.

Lavin MF.

Int J Biochem Cell Biol. 1999 Jul;31(7):735-40. Review.

PMID:
10467728
16.

Recombinase-activating gene (RAG) 2-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.

Petiniot LK, Weaver Z, Barlow C, Shen R, Eckhaus M, Steinberg SM, Ried T, Wynshaw-Boris A, Hodes RJ.

Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6664-9.

17.

Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways.

Barlow C, Brown KD, Deng CX, Tagle DA, Wynshaw-Boris A.

Nat Genet. 1997 Dec;17(4):453-6. Erratum in: Nat Genet 1998 Mar;18(3):298.

PMID:
9398849
18.

Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype.

Spring K, Cross S, Li C, Watters D, Ben-Senior L, Waring P, Ahangari F, Lu SL, Chen P, Misko I, Paterson C, Kay G, Smorodinsky NI, Shiloh Y, Lavin MF.

Cancer Res. 2001 Jun 1;61(11):4561-8.

19.

Atm deficiency results in severe meiotic disruption as early as leptonema of prophase I.

Barlow C, Liyanage M, Moens PB, Tarsounas M, Nagashima K, Brown K, Rottinghaus S, Jackson SP, Tagle D, Ried T, Wynshaw-Boris A.

Development. 1998 Oct;125(20):4007-17.

20.

Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice.

Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D.

Mol Cell Biol. 1998 Jul;18(7):4385-90.

Supplemental Content

Support Center